View drug registration information details.


ItemsRegistration information
ID681
No681
Brand NameUTROGESTAN 200 MG
IngredientsPROGESTERONE MICRONIZED PH EUR 200 MG
Dosage FormSOFT CAPSULE, ORAL ROUTE
Primary PackagingALU-PVC BLISTER PACK
StorageNO SPECIAL CONDITION
Shelf Life36 MONTHS
Pack SizeBOX OF 15'S
Dispensing CategoryPrescription only
ATC ClassificationG03DA04
Pharmaceutical ClassSEX HORMONE
IndicationsDISORDERS ASSOCIATED WITH A PROGESTERONE DEFICIT IN PARTICULAR: PRE-MENSTRUAL SYNDROME, MENSTRUAL IRREGULARITIES DUE TO OVULATION DISORDERS OR ANOVULATION, BENIGN MASTOPATHY, PREMENOPAUSE, INFERTILITY CAUSED BY LUTEAL PHASE DEFECT, MENACE OF PRETERM DELIVERY
ContraindicationsKNOWN HYPERSENSITIVITY TO THE ACTIVE SUBSTANCE OR ANY OF THE EXCIPIENT, SEVERE CHANGES IN HEPATIC FUNCTION
Side EffectsALTERED MENSTRUAL CYCLES, AMENORRHOEA, INTERMENSTRUAL BLEEDING, HEADACHE, DROWNSINESS, TRANSIENT DIZZINESS, CHOLESTATIC JAUDICE, PRURITUS, GASTROINTESTINAL DISORDERS.
Unit Price
EDL No
DescriptionOVOID, SLIGHTLY YELLOW CAPSULE CONTAING A WHITISH OILY SUSPENSION
Note
License OwnerEXAMED CO.,LTD
ManufacturerCYNDEA PHARMA, S.L.
CountryBELGIUM
Import Registration NoBE279386
Import Registration Date1981-09-01
ActivityCERTIFICATE RELEASED
Applied Date2024-10-01
FDD Registration No01 I 5170/22
FDD Registration Date2024-10-25
Expiry Date2029-10-24

Back to drug list